Uniunea Europeană - norvegiană - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - andre antianemic preparations - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.

Uniunea Europeană - norvegiană - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Norvegia - norvegiană - Statens legemiddelverk

navamedic asa - bjørkeblad / melbærblad / kjempegullris - tablett, drasjert

Norvegia - norvegiană - Statens legemiddelverk

faes farma - mesalazin - stikkpille - 1 g

Norvegia - norvegiană - Statens legemiddelverk

faes farma - mesalazin - stikkpille - 500 mg

Norvegia - norvegiană - Statens legemiddelverk

accord healthcare b.v. - anidulafungin - pulver til konsentrat til infusjonsvæske, oppløsning - 100 mg

Uniunea Europeană - norvegiană - EMA (European Medicines Agency)

serb sas - glucarpidase - metabolic side effects of drugs and substances - alle andre terapeutiske produkter - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.

Norvegia - norvegiană - Statens legemiddelverk

accord healthcare b.v. - vildagliptin - tablett - 50 mg

Uniunea Europeană - norvegiană - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.

Norvegia - norvegiană - Statens legemiddelverk

bioglan ab - anidulafungin - pulver til konsentrat til infusjonsvæske, oppløsning - 100 mg